Erratum: Novel method for quantitative evaluation of cardiac amyloidosis using 201TlCl and 99mTc-PYP SPECT (Annals of Nuclear Medicine (2012) DOI: 10.1007/s12149-012-0627-y);Novel method for quantitative evaluation of cardiac amyloidosis using 201TlCl and 99mTc-PYP SPECT

Annals of Nuclear Medicine

Volumn 26, Issue 8, 2012, Pages 634-643

  Yamamoto, Yasushi ^a,b   Onoguchi, Masahisa ^b   Haramoto, Masuo ^a   Kodani, Nobuhiro ^c   Komatsu, Akio ^a   Kitagaki, Hajime ^c   Tanabe, Kazuaki ^d  

^a SHIMANE UNIVERSITY HOSPITAL   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c SHIMANE UNIVERSITY   (Japan)

^d SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

Cardiac amyloidosis; Dual myocardial imaging; PYP scores

Indexed keywords

PYROPHOSPHATE TECHNETIUM TC 99M; THALLIUM CHLORIDE TL 201;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART AMYLOIDOSIS; HUMAN; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REFERENCE VALUE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 84867997584     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-012-0650-z     Document Type: Erratum

References (12)

1. Yamada M, Ikeda S, Higuchi K, Tamaoka A, Takaichi K, Toshiyuki Y, et al. The guideline for the medical care of an amyloidosis ver. 2010. A Ministry of Health, Labour and Welfare research group report. 2010. http://amyloid1.umin.ne. jp/guideline2010.pdf.
2. Tanaka J, Sawayama T, Hasegawa K. A symptomatography of organopathy and diagnostic procedure to be found in a generalized amyloidosis. Nihon Rinsho. 1991;49(4):841-6.
3. Hongo M, Misawa T, Yamada H, Hirayama J, Okubo S, Fujii T, et al. Diagnostic significance of Technetium-99m-pyrophosphate, technetium-99m- methylene diphosphonate and gallium-67-citrate scintigraphy in amyloid heart disease a study with AL amyloidosis and familial amyloid polyneuropathy. Nihon Naika Gakkai Zasshi. 1986;75(1):1-8.
4. Nagatomo Y, Ikushima I, Matsuyama A, Nakagawa S, Koiwaya Y, Kenjiro T. Cardiac manifestations in patient with systemic amyloidosis. Shinzou. 1987;19(3):277-85.
5. Hongo M, Yamada H, Okubo S, Hirayama J, Fujii T, Kusama S, et al. Cardiac involvement in systemic amyloidosis: Myocardial scintigraphic evaluation. J Cardiogr. 1985;15(1):163-80. (Pubitemid 15247374)
6. Imamoto T, Morita K, Onodera S, Tanazawa S, Amoh K, Ishikawa Y, et al. Technetium-99m-pyrophosphate single photon emission computed tomography of the heart in familial amyloid polyneuropathy: Comparison with thallium-201 myocardial scintigraphy-A case report. Kaku Igaku. 1988;25(10):1117-23.
7. Fujii T, Tanaka M, Yazaki Y, Kitabayashi H, Koizumi T, Hongou M, et al. Myocardial scintigraphic studies with 123I-MIBG, 201Tl and 99mTc-PYP in patients with cardiac amyloidosis. Kaku Igaku. 1997;34(11):1033-8.
8. Falk RH, Lee VW, Rubinow A, Hood WB, Cohen AS. Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis. Am J Cardiol. 1983;51(5):826-30. (Pubitemid 13141976)
9. Falk RH, Lee VW, Rubinow A, Skinner M, Cohen AS. Cardiac technetium-99m pyrophosphate scintigraphy in familial amyloidosis. Am J Cardiol. 1984;54(8):1150-1. (Pubitemid 15211615)
10. Takezaki M, Ishida Y, Morozumi R, Tani A, Satou H, Hori M, et al. Noninvasive diagnosis of cardiac involvement by technetium-99m-pyrophosphate(Tc- 99m PYP) myocardial scintigraphy in 2 case with familial amyloid polyneuropathy and 1 case with secondary amyloidosis. Kaku Igaku. 1989;26(12):1537-43. (Pubitemid 20080047)
11. Morozumi R, Hori M, Kamada T, Uehara T, Kusuoka H, Nishimura T, et al. Usefulness of technetium-99m pyrophosphoric acid scintigraphy in cardiac amyloidosis diagnosis. Prog Treat Cardiovasc Dis. 1995;14(1):28-32.
12. Yoshida K, Akasaka T, Itou H, Otsuji Y, Koyanagi S, Satomi M, et al. Guidelines for the clinical application of echocardiography (JCS2010). The Japanese Circulation Society. (2010) http://www. j-circ.or.jp/guideline/pdf/ JCS2010yoshida.d.pdf.